The Buyer Clarity Gap: Why Life Sciences OEM CMOs & CROs Lose Deals They Should Win

Summary

Life science OEM companies consistently win on clinical performance and lose in the buying committee room. McKinsey research (January 2026) finds that OEM manufacturers with customer-centric service models generate up to 35% of revenue from services, deliver 4× higher total shareholder returns, and achieve a 32% revenue increase from a 10–20% improvement in customer satisfaction. Yet most OEM buyer engagement architectures were not built to serve the institutional buyers — procurement, finance, IT, and clinical leadership — who now make these decisions collectively, often without a sales representative present.

This white paper examines the structural gap between how life sciences OEM organizations communicate value and how formal value analysis committees reach consensus. As buyers complete significant portions of their evaluation through self-guided enterprise evaluation, organizations delivering AI-guided buyer engagement across distributed buying committees are compressing 12-to-24-month cycles and building enterprise decision confidence that drives both initial wins and post-sale service growth.

Kaon Interactive’s Content Experience Platform enables OEM commercial leaders to deliver stakeholder-specific value narratives, centralize buyer orchestration, optimize content effectiveness, measure content engagement across buying committees, and improve content ROI throughout the customer lifecycle committee — and transform post-sale service into a strategic, recurring revenue asset.